Crossmark

A Highly Sensitive Immunoassay to Enable Quantification of a Nanobody-Based Imaging Agent in Human Serum

Published Online: 2025-02-03

Authors

Guelman, Sebastian https://orcid.org/0009-0003-8408-7333
Huang, Catherine

Peng, Kun
License Information

Text and Data Mining valid from 2025-02-03

Version of Record valid from 2025-02-03
More Information

Article History

Received: 3 December 2024

Accepted: 21 January 2025

First Online: 3 February 2025

Declarations

:

: All authors are employees of Genentech Inc., a member of the Roche group and Roche shareholders.

Document is current